NCDActive
Cavernous Nerves by Electrical Stimulation with Penile Plethsmography
NCD314
Effective: August 24, 2006
Updated: December 31, 2025
Policy Summary
Medicare does not cover cavernous nerve electrical stimulation with penile plethysmography (cavernosal nerve mapping) and has determined the test is not reasonable and necessary for beneficiaries undergoing nerve-sparing prostatic or colorectal surgical procedures (effective August 24, 2006). There are no nationally covered indications listed in this NCD; see §20.14 for related plethysmography policy. (NCD last reviewed September 2006.)
Coverage Criteria Preview
Key requirements from the full policy
"Cavernous nerve electrical stimulation with penile plethysmography (cavernosal nerve mapping) is non-covered by Medicare and is considered not reasonable and necessary for beneficiaries undergoing ..."
Sign up to see full coverage criteria, indications, and limitations.